search
Back to results

Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery

Primary Purpose

Inguinal Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Ibuprofen
Morphine
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inguinal Surgery focused on measuring Inguinal surgery, Hernia Repair, Orchidopexy, Hydrocele, Pediatric, Post-operative pain, Morphine sulfate, Ibuprofen

Eligibility Criteria

10 Months - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Pediatric Patients between the ages of 10 months-5 years at presentation to clinic
  2. Patients diagnosed with inguinal hernia or hydrocele, or undescended testes requiring surgical intervention by a trained physician
  3. Patients requiring inguinal day surgery

Exclusion Criteria:

  1. Patients who have undergone previous inguinal surgery
  2. Patients with other co-morbidities
  3. Patients unable to be prescribed Ibuprofen or Morphine
  4. Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDS) or opioids
  5. Patients with renal or hepatic failure
  6. Patients with coagulation disorders
  7. Deviation to pre-established anesthesia protocol
  8. Patients diagnosed with asthma or restrictive airways

Sites / Locations

  • McMaster Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Ibuprofen suspension

Morphine Sulfate suspension

Arm Description

Ibuprofen suspension (Advil) will be administered orally at a dose of 10mg/kg every 6 hours for 72 hours post-surgery.

Morphine sulfate suspension will be administered orally at a dose of 0.02 - 0.04 mg/kg every 6 hours for 72 hours post-surgery.

Outcomes

Primary Outcome Measures

Pain scales Post-Discharge from Hospital
Assessed through validated and reliable Parents Postoperative Pain Measure (PPPM) by trained and blinded parent/guardian at 24 hours and at 48 hour following discharge from the hospital.

Secondary Outcome Measures

Analgesic use post-operatively
Defined as the number of doses of Tylenol (15mg/kg) administered by PACU and SDSU nurses following surgery. Parents will record supplemental Tylenol administered in a pain diary for both arms of the study
Frequency of emesis (during hospital stay)
The frequency of emesis (vomiting) will be recorded by nurses at the recovery unit (post anesthetic care unit and same day surgery unit) during the patient's hospital stay.
Time to Discharge
The time it takes for the patient to be discharged from the hospital, beginning from when they first complete surgery.
Adverse reactions (during hospital stay)
Any complications that arise with the patient, during their recovery in the hospital.
Surgical complications
Any surgical complications that arise during the patient's surgery (surgical site infection, bleeding, wound dehiscence) will be assessed by a physician or nurse practitioner at 48-will be seen by the physician or nurse practitioner at the patient's 48-hour follow-up visit.
First bowel movement post-surgery
The first bowel movement post-surgery for the patient (during hospital stay or at home).

Full Information

First Posted
September 25, 2015
Last Updated
March 14, 2023
Sponsor
McMaster University
Collaborators
McMaster Surgical Associates
search

1. Study Identification

Unique Protocol Identification Number
NCT02603848
Brief Title
Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery
Official Title
Assessing the Effectiveness of Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery (AIMS)
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 27, 2017 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
February 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McMaster University
Collaborators
McMaster Surgical Associates

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Morphine is now the most commonly used opioid in children for pain management even though the safety of morphine use in children is a primary concern for parents as it is perceived to have more associated risks. Ibuprofen and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) have also been shown to be effective for the management of postoperative pain with fewer associated adverse effects. However, there have been concerns that utilization of ibuprofen alone may lead to inadequate pain management. Evidence of whether ibuprofen is equally effective as morphine for postoperative pain control in pediatric inguinal surgery is lacking and needs to be further explored as a measure to potentially reduce opioid exposure in children. To determine which drug is more effective for relieving post-operative pain, this trial will compare the effectiveness of ibuprofen and morphine at reducing post-operative pain, and the amount of analgesic use required post-surgery.
Detailed Description
The primary objective of this study is to determine the efficacy of ibuprofen in reducing postoperative pain in children recovering from inguinal surgery when compared to morphine. Thus, if stated as a research question, the problem to be addressed is: in children (10 months-5 years) who have recently undergone inguinal surgery, is ibuprofen, when administered postoperatively, no less effective in reducing postoperative pain compared to morphine? Inguinal surgical procedures (unilateral hernia/ hydrocele repair and unilateral orchidopexy) will be carried out under standardized analgesic administration. Anesthesia will be delivered to all participants via inhalation induction with air/nitrous oxide and sevoflurane, intravenous supplementation with propofol and/or fentanyl 1 to 2 mcg/kg, antiemetic prophylaxis with dexamethasone 150 mcg/kg and ondansetron 50 mcg/kg, acetaminophen suppository 40 mg/kg, and morphine intravenous 50-100 mcg/kg. Regional block with local infiltration of 0.25 % of plain bupivacaine will be performed around the vicinity of the ileoinguinal nerve. This anesthesia protocol has been approved by a consensus meeting with the Pediatric Anesthesia Group at McMaster University and will be employed consistently in all cases in this study. Deviations to this practice will lead to study exclusion. Postoperatively, the control group will receive standardized 0.2 mg/ kg morphine syrup (maximum 10mg) every four hours as needed, while the intervention group will receive Ibuprofen suspension (10mg/kg; maximum 600 mg) every six hours as needed for 48 hours post hospital discharge. Tylenol (15mg/kg) can be administered in either group at parental discretion every four hours as needed and will be recorded in a standardized medication log provided to all parents. Parents will be told to follow the instructions on the package of prefilled syringes (i.e. to give the medication every 4 hours or 6 hours as needed) by the healthcare practitioner who is discharging the patient from the hospital. Parents and will not be told which medication their child is receiving in order to maintain blinding. All dosage information will be kept and maintained by the research pharmacy staff. Parents will be provided medication information through the use of a standardized script and hand out available in both English and French which will encompass potential side effects of both trial medications. The duration of the treatment period will be following hospital discharge, after the inguinal surgical procedure, to 48 hours post-hospital discharge. Primary Outcome Measurement Tool: Postoperative pain will be measured at three time the evening of the procedure, 24 hours post-discharge and 48 hours post-discharge) using the validated Parents Postoperative Pain Measure (PPPM) (See Appendix A).10 Pain scales will only be administered by parents once the patient has been discharged home. Patients usually recover from surgery for an average of two hours prior to being discharged from hospital. Secondary Outcomes Measurement Tool: Secondary outcomes will be measured as follows: 1) Analgesic use postoperatively while still in the hospital. This will be recorded by a member of the care team on the patient's chart. Parents will record supplemental Tylenol administered in a standardized medication log for both arms of the study; 2) Frequency of emesis during recovery phase (in hospital and post discharge) recorded on patient case report form and recorded from the 48 hour phone call. 3) Time to discharge will be recorded from patient discharge sheet by research assistant 4) Adverse reactions (post discharge) will be recorded on patient case report form 5) Surgical complications (surgical site infection, bleeding, wound dehiscence) will be assessed by a physician or nurse practitioner at 6-8 week follow-up visit 6) First bowel movement post-surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Surgery
Keywords
Inguinal surgery, Hernia Repair, Orchidopexy, Hydrocele, Pediatric, Post-operative pain, Morphine sulfate, Ibuprofen

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ibuprofen suspension
Arm Type
Experimental
Arm Description
Ibuprofen suspension (Advil) will be administered orally at a dose of 10mg/kg every 6 hours for 72 hours post-surgery.
Arm Title
Morphine Sulfate suspension
Arm Type
Active Comparator
Arm Description
Morphine sulfate suspension will be administered orally at a dose of 0.02 - 0.04 mg/kg every 6 hours for 72 hours post-surgery.
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Other Intervention Name(s)
Advil
Intervention Description
(10mg/kg; maximum 600 mg) every six hours as needed
Intervention Type
Drug
Intervention Name(s)
Morphine
Other Intervention Name(s)
Morphine sulfate
Intervention Description
0.2 mg/ kg morphine suspension (maximum 10mg) every four hours as needed
Primary Outcome Measure Information:
Title
Pain scales Post-Discharge from Hospital
Description
Assessed through validated and reliable Parents Postoperative Pain Measure (PPPM) by trained and blinded parent/guardian at 24 hours and at 48 hour following discharge from the hospital.
Time Frame
Postoperative pain will be measured at three time the evening of the procedure, 24 hours post-discharge and 48 hours post-discharge) using the validated Parents Postoperative Pain Measure (PPPM)
Secondary Outcome Measure Information:
Title
Analgesic use post-operatively
Description
Defined as the number of doses of Tylenol (15mg/kg) administered by PACU and SDSU nurses following surgery. Parents will record supplemental Tylenol administered in a pain diary for both arms of the study
Time Frame
Measured dosage post-surgery (on average 45 minutes later)
Title
Frequency of emesis (during hospital stay)
Description
The frequency of emesis (vomiting) will be recorded by nurses at the recovery unit (post anesthetic care unit and same day surgery unit) during the patient's hospital stay.
Time Frame
From the time surgical procedure is completed to discharge from the hospital. (Typically two to four hours)
Title
Time to Discharge
Description
The time it takes for the patient to be discharged from the hospital, beginning from when they first complete surgery.
Time Frame
Time from the end of the surgical procedure to discharge from hospital. (Typically two to four hours)
Title
Adverse reactions (during hospital stay)
Description
Any complications that arise with the patient, during their recovery in the hospital.
Time Frame
Any complications that arise during the patient's recovery at the hospital (Typically two to four hours)
Title
Surgical complications
Description
Any surgical complications that arise during the patient's surgery (surgical site infection, bleeding, wound dehiscence) will be assessed by a physician or nurse practitioner at 48-will be seen by the physician or nurse practitioner at the patient's 48-hour follow-up visit.
Time Frame
Surgical complications will be seen at the patient's 48-hour follow-up visit.
Title
First bowel movement post-surgery
Description
The first bowel movement post-surgery for the patient (during hospital stay or at home).
Time Frame
The first bowel movement for the patient after surgery (Immediately after surgery to 3 Days post surgery)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pediatric Patients between the ages of 10 months-5 years at presentation to clinic Patients diagnosed with inguinal hernia or hydrocele, or undescended testes requiring surgical intervention by a trained physician Patients requiring inguinal day surgery Exclusion Criteria: Patients who have undergone previous inguinal surgery Patients with other co-morbidities Patients unable to be prescribed Ibuprofen or Morphine Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDS) or opioids Patients with renal or hepatic failure Patients with coagulation disorders Deviation to pre-established anesthesia protocol Patients diagnosed with asthma or restrictive airways
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Luis Braga, MD
Phone
905-521-2100
Ext
73777
Email
braga@mcmaster.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Melissa McGrath
Phone
905-521-2100
Ext
73654
Email
mcgram2@mcmaster.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luis Braga, MD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster Children's Hospital
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 3Z5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luis Braga, MD
Phone
905-521-2100
Ext
73777
Email
braga@mcmaster.ca

12. IPD Sharing Statement

Links:
URL
https://surgery.mcmaster.ca/divisions/pediatric-surgery/research/mpsrc/studies/aims
Description
McMaster Pediatric Surgery Research Collaborative

Learn more about this trial

Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery

We'll reach out to this number within 24 hrs